JNJ-77242113 Study Initiated for Moderate to Severe Plaque Psoriasis
A clinical trial has been initiated to evaluate the efficacy of JNJ-77242113 in treating moderate to severe plaque psoriasis.
Asset / Drug
Drug and asset intelligence for Moderate with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.